相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Radioimmunotherapy with a- particle- emitting radionuclides
Christof Seidl
IMMUNOTHERAPY (2014)
Chemotherapeutic and targeted biological agents for metastatic bladder cancer: A comprehensive review
Terence T. Sio et al.
INTERNATIONAL JOURNAL OF UROLOGY (2014)
Antitumor Immunity Induced after α Irradiation
Jean-Baptiste Gorin et al.
NEOPLASIA (2014)
Radioimmunotherapy for hematopoietic cell transplantation
Joseph G. Jurcic
IMMUNOTHERAPY (2013)
Radioimmunotherapy for peritoneal cancers
Christof Seidl et al.
IMMUNOTHERAPY (2013)
General overview of radioimmunotherapy of solid tumors
Isabelle Navarro-Teulon et al.
IMMUNOTHERAPY (2013)
Bladder cancer, a review of the environmental risk factors
Silvia Letasiova et al.
ENVIRONMENTAL HEALTH (2012)
Phase II Trial of Cetuximab With or Without Paclitaxel in Patients With Advanced Urothelial Tract Carcinoma
Yu-Ning Wong et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Bismuth-213 and Actinium-225 - Generator Performance and Evolving Therapeutic Applications of Two Generator-Derived Alpha-Emitting Radioisotopes
Alfred Morgenstern et al.
CURRENT RADIOPHARMACEUTICALS (2012)
Targeted Alpha Therapy with Bi-213
Alfred Morgenstern et al.
CURRENT RADIOPHARMACEUTICALS (2011)
Toxicity and Relative Biological Effectiveness of Alpha Emitting Radioimmunoconjugates
Jostein Dahle et al.
CURRENT RADIOPHARMACEUTICALS (2011)
Diagnosis, evaluation and treatment of carcinoma in situ of the urinary bladder: The state of the art
Sean R. Williamson et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)
Mouse orthotopic models for bladder cancer research
Eddie Chan et al.
BJU INTERNATIONAL (2009)
Recurrence and Progression of Disease in Non-Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
Bas W. G. van Rhijn et al.
EUROPEAN UROLOGY (2009)
Intravesical α-Radioimmunotherapy with 213Bi-Anti-EGFR-mAb Defeats Human Bladder Carcinoma in Xenografted Nude Mice
Birgit Pfost et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Optimizing Orthotopic Bladder Tumor Implantation in a Syngeneic Mouse Model
Eddie S. Y. Chan et al.
JOURNAL OF UROLOGY (2009)
Radioimmunotherapy of human bladder cancer in a nude mouse model comparing Bi-213-anti-EGFR-MAb and Th-226-anti-EGFR-MAb
Birgit Pfost et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Noninvasive bioluminescence imaging in small animals
Kurt R. Zinn et al.
ILAR JOURNAL (2008)
The global burden of urinary bladder cancer
D. Maxwell Parkin
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2008)
A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging
Boris A. Hadaschik et al.
BJU INTERNATIONAL (2007)
Non-invasive visualisation of the development of peritoneal carcinomatosis and tumour regression after 213Bi-radioimmunotherapy using bioluminescence imaging
H. Matthias Buchhorn et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Cancer statistics, 2007
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
Expression of the epidermal growth factor receptor family in normal and malignant urothelium
R Rotterud et al.
BJU INTERNATIONAL (2005)
Cell death triggered by alpha-emitting 213Bi-immunoconjugates in HSC45-M2 gastric cancer cells is different from apoptotic cell death
C Seidl et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: A meta-analysis of published results of randomized clinical trials
RJ Sylvester et al.
JOURNAL OF UROLOGY (2004)
Epidermal growth factor receptor and bladder cancer
AJ Colquhoun et al.
POSTGRADUATE MEDICAL JOURNAL (2002)
Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions
D Zaak et al.
CANCER (2002)
An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies
T Watanabe et al.
CANCER GENE THERAPY (2000)
分享论文
